Pfizer
Towards A ‘Decarbonized Future’
The temporary “emission reduction due to the COVID-19 lockdown” is not a significant one.
Pfizer’s ACMF Wins The ‘2020 Facility of the Year Award’
CRB has designed and engineered the ACMF allowing Pfizer to expand its clinical manufacturing.
‘The Time To Act Is Now’
Private-public partnership strives to eliminate NTDs by following an action blueprint and meets with success particularly with Trachoma.
Dynamically Addressing ‘Global Health Challenges’ Pfizer Battles Trachoma In Children
Pfizer finds promising results in the mortality reduction among children who combating trachoma.
Pfizer Prioritizes On Refugees’ Needs To Collaboratively ‘Prevent Disease’ In Some ‘Most Vulnerable Populations’ In The World
Besides delivering product assistance and financial support, Pfizer is all out with its “other resources” to improve global healthcare.
Striking A Balance Between Acceleration & Quality With The Help Of Resources
Pfizer brings its business goals and its responsibilities towards the society at large under the sale roof.
Pfizer’s Annual Report Of 2016 Enumerates Detailed Information About Its Goals & Performances
Pfizer’s daily endeavour to improve the patient impact worldwide continues to become better with the passing years.
